Literature DB >> 23345212

Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death.

David B Wang1, Gwenn A Garden, Chizuru Kinoshita, Cody Wyles, Nasim Babazadeh, Bryce Sopher, Yoshito Kinoshita, Richard S Morrison.   

Abstract

Maintaining proper mitochondrial length is essential for normal mitochondrial function in neurons. Mitochondrial fragmentation has been associated with neuronal cell death caused by a variety of experimental toxic stressors. Despite the fact that oxidative stress is a hallmark of neurodegenerative conditions and aging and the resulting activation of p53 is believed to contribute to the neuropathology, little is still known regarding changes in mitochondrial morphology in p53-dependent neuronal death. Therefore, we specifically addressed the relationship between genotoxic stress, p53 activation, and the regulation of mitochondrial morphology in neurons. In cultured postnatal mouse cortical neurons, treatment with the DNA-damaging agent camptothecin (CPT) resulted in elongated mitochondria, in contrast to fragmented mitochondria observed upon staurosporine and glutamate treatment. In fibroblasts, however, CPT resulted in fragmented mitochondria. CPT treatment in neurons suppressed expression of the mitochondrial fission protein Drp1 and the E3 ubiquitin ligase parkin. The presence of elongated mitochondria and the declines in Drp1 and parkin expression occurred before the commitment point for apoptosis. The CPT-induced changes in Drp1 and parkin were not observed in p53-deficient neurons, while p53 overexpression alone was sufficient to reduce the expression of the two proteins. Elevating Drp1 or parkin expression before CPT treatment enhanced neuronal viability and restored a normal pattern of mitochondrial morphology. The present findings demonstrate that genotoxic stress in neurons results in elongated mitochondria in contrast to fission induced by other forms of stress, and p53-dependent declines in Drp1 and parkin levels contribute to altered mitochondrial morphology and cell death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345212      PMCID: PMC3711762          DOI: 10.1523/JNEUROSCI.3365-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.

Authors:  Frédéric Darios; Olga Corti; Christoph B Lücking; Cornelia Hampe; Marie-Paule Muriel; Nacer Abbas; Wen-Jie Gu; Etienne C Hirsch; Thomas Rooney; Merle Ruberg; Alexis Brice
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

Review 3.  Mitochondrial fission in apoptosis.

Authors:  Richard J Youle; Mariusz Karbowski
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

4.  p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

Authors:  Byoung-Il Bae; Hong Xu; Shuichi Igarashi; Masahiro Fujimuro; Nishant Agrawal; Yoichi Taya; S Diane Hayward; Timothy H Moran; Craig Montell; Christopher A Ross; Solomon H Snyder; Akira Sawa
Journal:  Neuron       Date:  2005-07-07       Impact factor: 17.173

5.  Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons.

Authors:  Mark J Barsoum; Hua Yuan; Akos A Gerencser; Géraldine Liot; Yulia Kushnareva; Simone Gräber; Imre Kovacs; Wilson D Lee; Jenna Waggoner; Jiankun Cui; Andrew D White; Blaise Bossy; Jean-Claude Martinou; Richard J Youle; Stuart A Lipton; Mark H Ellisman; Guy A Perkins; Ella Bossy-Wetzel
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

6.  Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.

Authors:  Maja T Tomicic; Markus Christmann; Bernd Kaina
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

7.  Evidence for p53-mediated modulation of neuronal viability.

Authors:  H Xiang; D W Hochman; H Saya; T Fujiwara; P A Schwartzkroin; R S Morrison
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

8.  Bax involvement in p53-mediated neuronal cell death.

Authors:  H Xiang; Y Kinoshita; C M Knudson; S J Korsmeyer; P A Schwartzkroin; R S Morrison
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

9.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways.

Authors:  U K Messmer; B Brüne
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

10.  The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.

Authors:  S Frank; B Gaume; E S Bergmann-Leitner; W W Leitner; E G Robert; F Catez; C L Smith; R J Youle
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

View more
  31 in total

1.  Parkin Overexpression Ameliorates PrP106-126-Induced Neurotoxicity via Enhanced Autophagy in N2a Cells.

Authors:  Sher Hayat Khan; Deming Zhao; Syed Zahid Ali Shah; Mohammad Farooque Hassan; Ting Zhu; Zhiqi Song; Xiangmei Zhou; Lifeng Yang
Journal:  Cell Mol Neurobiol       Date:  2016-07-18       Impact factor: 5.046

2.  Fully automated software for quantitative measurements of mitochondrial morphology.

Authors:  P Mason McClatchey; Amy C Keller; Ron Bouchard; Leslie A Knaub; Jane E B Reusch
Journal:  Mitochondrion       Date:  2015-12-11       Impact factor: 4.160

3.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

Review 4.  Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury.

Authors:  Selva Baltan; Richard S Morrison; Sean P Murphy
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

5.  LIM kinase-2 induces programmed necrotic neuronal death via dysfunction of DRP1-mediated mitochondrial fission.

Authors:  J-E Kim; H J Ryu; M J Kim; T-C Kang
Journal:  Cell Death Differ       Date:  2014-02-21       Impact factor: 15.828

Review 6.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

7.  Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo.

Authors:  Xing Guo; Hiromi Sesaki; Xin Qi
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

8.  Bax interacting factor-1 promotes survival and mitochondrial elongation in neurons.

Authors:  David B Wang; Takuma Uo; Chizuru Kinoshita; Bryce L Sopher; Rona J Lee; Sean P Murphy; Yoshito Kinoshita; Gwenn A Garden; Hong-Gang Wang; Richard S Morrison
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  Nitrite augments glucose uptake in adipocytes through the protein kinase A-dependent stimulation of mitochondrial fusion.

Authors:  Nicholas K H Khoo; Li Mo; Sergey Zharikov; Christelle Kamga-Pride; Kelly Quesnelle; Franca Golin-Bisello; Lihua Li; Yinna Wang; Sruti Shiva
Journal:  Free Radic Biol Med       Date:  2014-02-17       Impact factor: 7.376

10.  HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Elisabeth Serger; Sofia Campos; Ajit S Divakaruni; Changyoun Kim; Kendall Smith; Margarita Trejo; Anthony Adame; Brian Spencer; Edward Rockenstein; Anne N Murphy; Ronald J Ellis; Scott Letendre; Igor Grant; Eliezer Masliah
Journal:  Neurobiol Dis       Date:  2015-11-22       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.